These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7654939)

  • 41. Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.
    Chopra N; Koren S; Greer WL; Fortin PR; Rauch J; Fortin I; Senécal JL; Docherty P; Hanly JG
    J Rheumatol; 2002 Aug; 29(8):1683-8. PubMed ID: 12180730
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Activated C protein resistance: laboratory study and prevalence of the defect in the Chilean population].
    Pereira J; Quiroga T; Goycoolea M; Muñoz B; Hidalgo P; Kaltwasser G; Mezzano D
    Rev Med Chil; 1996 Jun; 124(6):663-8. PubMed ID: 9041721
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multiplex PCR for one-step determination of the G20210A variation and the factor V Leiden mutation by denaturing gradient gel electrophoresis (DGGE).
    Patri S; Salmeron S; Caillon M; Kitzis A; Chomel JC
    Thromb Haemost; 1999 Feb; 81(2):313-4. PubMed ID: 10064013
    [No Abstract]   [Full Text] [Related]  

  • 44. Probability of recurrence of thrombosis in patients with and without factor V Leiden.
    Rintelen C; Pabinger I; Knöbl P; Lechner K; Mannhalter C
    Thromb Haemost; 1996 Feb; 75(2):229-32. PubMed ID: 8815565
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of mutated factor V ARG506 to GLN in Italians.
    De Stefano V; Voso MT; Chiusolo P; Paciaroni K; Bizzi B; Leone G
    Thromb Haemost; 1997 Jan; 77(1):216-7. PubMed ID: 9031477
    [No Abstract]   [Full Text] [Related]  

  • 46. High heterozygosity frequency of three exonic SNPs of factor V gene (F5): implications for genetic diagnosis.
    Jadli A; Kulkarni B; Ghosh K; Shetty S
    Indian J Med Res; 2015 Jul; 142(1):85-7. PubMed ID: 26261171
    [No Abstract]   [Full Text] [Related]  

  • 47. Biochemical prototype for familial thrombosis. A study combining a functional protein C mutation and factor V Leiden.
    Kalafatis M; Lu D; Bertina RM; Long GL; Mann KG
    Arterioscler Thromb Vasc Biol; 1995 Dec; 15(12):2181-7. PubMed ID: 7489240
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutation in the gene coding for coagulation factor V and resistance to activated protein C: detection of the genetic mutation by oligonucleotide ligation assay using a semi-automated system.
    Zotz RB; Maruhn-Debowski B; Scharf RE
    Thromb Haemost; 1996 Jul; 76(1):53-5. PubMed ID: 8819251
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis.
    Kim TW; Kim WK; Lee JH; Kim SB; Kim SW; Suh C; Lee KH; Lee JS; Seo EJ; Chi HS; Kim SH
    J Korean Med Sci; 1998 Dec; 13(6):587-90. PubMed ID: 9886165
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders.
    Dahlbäck B
    Int J Lab Hematol; 2016 May; 38 Suppl 1():4-11. PubMed ID: 27161771
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Two novel mutations responsible for hereditary type I protein C deficiency: characterization by denaturing gradient gel electrophoresis.
    Gandrille S; Vidaud M; Aiach M; Alhenc-Gelas M; Fischer AM; Gouault-Heilman M; Toulon P; Fiessinger JN; Goossens M
    Hum Mutat; 1992; 1(6):491-500. PubMed ID: 1301959
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ischaemic stroke in infancy and childhood: role of the Arg506 to Gln mutation in the factor V gene.
    Nowak-Göttl U; Sträter R; Dübbers A; Oleszuk-Raschke K; Vielhaber H
    Blood Coagul Fibrinolysis; 1996 Oct; 7(7):684-8. PubMed ID: 8958390
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activated protein C resistance in ischemic stroke not due to factor V arginine506-->glutamine mutation.
    Fisher M; Fernandez JA; Ameriso SF; Xie D; Gruber A; Paganini-Hill A; Griffin JH
    Stroke; 1996 Jul; 27(7):1163-6. PubMed ID: 8685921
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Arg506Gln mutation (FV Leiden) among a cohort of 4188 unselected Danish newborns.
    Larsen TB; Lassen JF; Brandslund I; Byriel L; Petersen GB; Nørgaard-Pedersen B
    Thromb Res; 1998 Mar; 89(5):211-5. PubMed ID: 9645914
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incidence of Arg506 --> Gln mutation (factor V Leiden) in Pima Indians.
    Kohler HP; Boothby M; McCormack L; Knowler WC; Grant PJ
    Thromb Haemost; 1997 Aug; 78(2):961-2. PubMed ID: 9268205
    [No Abstract]   [Full Text] [Related]  

  • 56. Two mutations in exon XII of the protein S alpha gene in four thrombophilic families resulting in premature stop codons and depressed levels of mutated mRNA.
    Andersen BD; Lind B; Philips M; Hansen AB; Ingerslev J; Thorsen S
    Thromb Haemost; 1996 Aug; 76(2):143-50. PubMed ID: 8865520
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Single point mutation at Arg506 of factor V associated with APC resistance and venous thromboembolism: improved detection by PCR-mediated site-directed mutagenesis.
    Rabès JP; Trossaert M; Conard J; Samama M; Giraudet P; Boileau C
    Thromb Haemost; 1995 Nov; 74(5):1379-80. PubMed ID: 8607126
    [No Abstract]   [Full Text] [Related]  

  • 58. Identification of a large deletion and three novel mutations in exon 13 of the factor V gene in a Spanish family with normal factor V coagulant and anticoagulant properties.
    Soria JM; Blangero J; Souto JC; Martínez-Sánchez E; Martínez-Marchán E; Coll I; Tirado I; Cercós A; Almasy L; Fontcuberta J
    Hum Genet; 2002 Jul; 111(1):59-65. PubMed ID: 12136237
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of denaturing gradient gel electrophoresis to detect point mutations in the factor VIII gene.
    Traystman MD; Higuchi M; Kasper CK; Antonarakis SE; Kazazian HH
    Genomics; 1990 Feb; 6(2):293-301. PubMed ID: 2106480
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of the R485K polymorphism of the factor V gene with poor response to activated protein C and increased risk of coronary artery disease in the Chinese population.
    Le W; Yu JD; Lu L; Tao R; You B; Cai X; Cao WJ; Huang W; He RM; Zhu DL; Chen Z; Gong LS
    Clin Genet; 2000 Apr; 57(4):296-303. PubMed ID: 10845571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.